JPMORGAN CHASE & CO - CELL THERAPEUTICS INC ownership

CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 66 filers reported holding CELL THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CELL THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$35,000
+75.0%
10,2140.0%0.00%
Q4 2013$20,000
-20.0%
10,214
-35.1%
0.00%
Q3 2013$25,000
-76.4%
15,729
-84.4%
0.00%
Q2 2013$106,000100,5680.00%
Other shareholders
CELL THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 400,000$1,360,0000.31%
TFS CAPITAL LLC 1,351,073$4,594,0000.30%
Geduld E E 100,000$340,0000.18%
OXFORD ASSET MANAGEMENT LLP 1,429,215$4,859,0000.14%
EAGLE ASSET MANAGEMENT INC 6,718,484$22,842,0000.13%
First Heartland Consultants, Inc. 74,624$254,0000.12%
WASHINGTON TRUST Co 410,616$1,396,0000.10%
FIRST NEW YORK SECURITIES LLC /NY 50,000$170,0000.08%
Tradeworx Inc. 16,704$57,0000.05%
LMR Partners LLP 103,643$352,0000.05%
View complete list of CELL THERAPEUTICS INC shareholders